News
Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults ... the basis of regulatory filing to extend the label for Vaxneuvance later this year, according ...
Ligand Pharmaceuticals offers biotech exposure with reduced risk through its royalty platform. Discover why its valuation now ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...
In addition to increasing vaccine coverage in older adults, they need to monitor the changing epidemiology of pneumococcal serotypes causing invasive disease. [134] In the face of these changes ...
Pneumococcal conjugate vaccines, including more than seven serotypes, will have potential for a larger effect than PCV7 in many countries, including Norway. A 13-valent pneumococcal conjugate ...
Over the past five decades, vaccinations have prevented more than 150 million deaths among humans from deadly infectious diseases. The once-dreaded infection small pox for instance, had been ...
Health and Human Services Secretary Robert F. Kennedy Jr. said the measles vaccine is "leaky" because its effectiveness wanes over time, something medical experts dispute. Kennedy, a vaccine ...
A majority of the Centers for Disease Control and Prevention's work group on COVID-19 vaccines now supports ending the agency's pandemic-era recommendation for virtually all Americans to get ...
Vaccinations are key amid recent measles outbreaks in the U.S., including Michigan. Here's a look at what to know.
Maintaining current vaccinations, particularly the pneumococcal vaccine, provides protection against certain bacteria commonly responsible for ear infections. Seasonal flu shots also reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results